The article focuses on ureteral stenting. It presents the case of forgotten stent, a case allegedly common in urological practice, to discuss developments in degradable stent using biocompatible L-polyglycolic acid and caprolactone combination. It also offers recommendations on how forgotten stents can be avoided, such asthe use of stent registries, automated electronic reminder system, and staff monitoring of patients for stent removal.